387 related articles for article (PubMed ID: 16822227)
1. Intravail: highly effective intranasal delivery of peptide and protein drugs.
Maggio ET
Expert Opin Drug Deliv; 2006 Jul; 3(4):529-39. PubMed ID: 16822227
[TBL] [Abstract][Full Text] [Related]
2. Recent progress in protein and peptide delivery by noninvasive routes.
Wearley LL
Crit Rev Ther Drug Carrier Syst; 1991; 8(4):331-94. PubMed ID: 1769066
[TBL] [Abstract][Full Text] [Related]
3. Improvement of Intranasal Drug Delivery with Intravail
Rabinowicz AL; Carrazana E; Maggio ET
Drugs R D; 2021 Dec; 21(4):361-369. PubMed ID: 34435339
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs.
Marttin E; Verhoef JC; Merkus FW
J Drug Target; 1998; 6(1):17-36. PubMed ID: 9769018
[TBL] [Abstract][Full Text] [Related]
5. Review: clinical opportunities provided by the nasal administration of peptides.
Harris AS
J Drug Target; 1993; 1(2):101-16. PubMed ID: 8069548
[TBL] [Abstract][Full Text] [Related]
6. Intranasal delivery of systemic-acting drugs: small-molecules and biomacromolecules.
Fortuna A; Alves G; Serralheiro A; Sousa J; Falcão A
Eur J Pharm Biopharm; 2014 Sep; 88(1):8-27. PubMed ID: 24681294
[TBL] [Abstract][Full Text] [Related]
7. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.
O'Hagan DT; Illum L
Crit Rev Ther Drug Carrier Syst; 1990; 7(1):35-97. PubMed ID: 2257636
[TBL] [Abstract][Full Text] [Related]
8. Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male Swiss Webster mice: a study comparing the pharmacokinetics of oral delivery to intraperitoneal, subcutaneous, intramuscular, and intranasal administration.
Lee DW; Leinung MC; Grasso P
Regul Pept; 2010 Feb; 160(1-3):129-32. PubMed ID: 20026361
[TBL] [Abstract][Full Text] [Related]
9. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation.
Zaki NM; Mortada ND; Awad GA; Abd ElHady SS
Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453
[TBL] [Abstract][Full Text] [Related]
10. Approaches towards enhanced transepithelial drug delivery.
Majumdar S; Mitra AK
Discov Med; 2006 Dec; 6(36):229-33. PubMed ID: 17250788
[TBL] [Abstract][Full Text] [Related]
11. Nasal drug delivery - recent developments and future prospects.
Illum L
J Control Release; 2012 Jul; 161(2):254-63. PubMed ID: 22300620
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptides for drug delivery across membrane barriers.
Foged C; Nielsen HM
Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
[TBL] [Abstract][Full Text] [Related]
13. The nasal delivery of systemic drugs.
Jones NS; Quraishi S; Mason JD
Int J Clin Pract; 1997; 51(5):308-11. PubMed ID: 9489091
[TBL] [Abstract][Full Text] [Related]
14. High efficiency intranasal drug delivery using Intravail® alkylsaccharide absorption enhancers.
Maggio ET; Pillion DJ
Drug Deliv Transl Res; 2013 Feb; 3(1):16-25. PubMed ID: 25787864
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in drug delivery systems: intranasal drug delivery.
Agarwal V; Mishra B
Indian J Exp Biol; 1999 Jan; 37(1):6-16. PubMed ID: 10355359
[TBL] [Abstract][Full Text] [Related]
16. Nonparenteral administration of peptide and protein drugs.
Siddiqui O; Chien YW
Crit Rev Ther Drug Carrier Syst; 1987; 3(3):195-208. PubMed ID: 3549006
[TBL] [Abstract][Full Text] [Related]
17. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications.
Sahni JK; Chopra S; Ahmad FJ; Khar RK
J Pharm Pharmacol; 2008 Sep; 60(9):1111-9. PubMed ID: 18718113
[TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of mouse [D-Leu-4]OB3, a synthetic peptide amide with leptin-like activity, enhances total uptake and bioavailability in Swiss Webster mice when compared to intraperitoneal, subcutaneous, and intramuscular delivery systems.
Novakovic ZM; Leinung MC; Lee DW; Grasso P
Regul Pept; 2009 Apr; 154(1-3):107-11. PubMed ID: 19344673
[TBL] [Abstract][Full Text] [Related]
19. [Intranasal delivery of systemic drugs: a new route for opioid drugs].
Devillier P; Grassin-Delyle S; Naline E; Buenestado A; Blouquit-Laye S; Advenier C
Therapie; 2010; 65(5):475-81. PubMed ID: 21144483
[TBL] [Abstract][Full Text] [Related]
20. Alternative delivery systems for peptides and proteins as drugs.
Eppstein DA; Longenecker JP
Crit Rev Ther Drug Carrier Syst; 1988; 5(2):99-139. PubMed ID: 3052876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
